PMID- 25694483 OWN - NLM STAT- MEDLINE DCOM- 20150804 LR - 20220129 IS - 1522-1466 (Electronic) IS - 1522-1466 (Linking) VI - 308 IP - 10 DP - 2015 May 15 TI - The swan-neck lesion: proximal tubular adaptation to oxidative stress in nephropathic cystinosis. PG - F1155-66 LID - 10.1152/ajprenal.00591.2014 [doi] AB - Cystinosis is an inherited disorder resulting from a mutation in the CTNS gene, causing progressive proximal tubular cell flattening, the so-called swan-neck lesion (SNL), and eventual renal failure. To determine the role of oxidative stress in cystinosis, histologic sections of kidneys from C57BL/6 Ctns(-/-) and wild-type mice were examined by immunohistochemistry and morphometry from 1 wk to 20 mo of age. Additional mice were treated from 1 to 6 mo with vehicle or mitoquinone (MitoQ), an antioxidant targeted to mitochondria. The leading edge of the SNL lost mitochondria and superoxide production, and became surrounded by a thickened tubular basement membrane. Progression of the SNL as determined by staining with lectin from Lotus tetragonolobus accelerated after 3 mo, but was delayed by treatment with MitoQ (38 +/- 4% vs. 28 +/- 1%, P < 0.01). Through 9 mo, glomeruli had retained renin staining and intact macula densa, whereas SNL expressed transgelin, an actin-binding protein, but neither kidney injury molecule-1 (KIM-1) nor cell death was observed. After 9 mo, clusters of proximal tubules exhibited localized oxidative stress (4-hydroxynonenal binding), expressed KIM-1, and underwent apoptosis, leading to the formation of atubular glomeruli and accumulation of interstitial collagen. We conclude that nephron integrity is initially maintained in the Ctns(-/-) mouse by adaptive flattening of cells of the SNL through loss of mitochondria, upregulation of transgelin, and thickened basement membrane. This adaptation ultimately fails in adulthood, with proximal tubular disruption, formation of atubular glomeruli, and renal failure. Antioxidant treatment targeted to mitochondria delays initiation of the SNL, and may provide therapeutic benefit in children with cystinosis. CI - Copyright (c) 2015 the American Physiological Society. FAU - Galarreta, Carolina I AU - Galarreta CI AD - Department of Pediatrics, University of Virginia, Charlottesville, Virginia; FAU - Forbes, Michael S AU - Forbes MS AD - Department of Pediatrics, University of Virginia, Charlottesville, Virginia; FAU - Thornhill, Barbara A AU - Thornhill BA AD - Department of Pediatrics, University of Virginia, Charlottesville, Virginia; FAU - Antignac, Corinne AU - Antignac C AD - Inserm U1163, Laboratory of Hereditary Kidney Diseases, and Paris Descartes-Sorbonne Paris Cite University, Imagine Institute, Paris, France; and. FAU - Gubler, Marie-Claire AU - Gubler MC AD - Inserm U1163, Laboratory of Hereditary Kidney Diseases, and Paris Descartes-Sorbonne Paris Cite University, Imagine Institute, Paris, France; and. FAU - Nevo, Nathalie AU - Nevo N AD - Inserm U1163, Laboratory of Hereditary Kidney Diseases, and Paris Descartes-Sorbonne Paris Cite University, Imagine Institute, Paris, France; and. FAU - Murphy, Michael P AU - Murphy MP AD - MRC Mitochondrial Biology Unit, Cambridge, United Kingdom. FAU - Chevalier, Robert L AU - Chevalier RL AD - Department of Pediatrics, University of Virginia, Charlottesville, Virginia; RLC2M@virginia.edu. LA - eng GR - MC_U105663142/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150218 PL - United States TA - Am J Physiol Renal Physiol JT - American journal of physiology. Renal physiology JID - 100901990 RN - 0 (Amino Acid Transport Systems, Neutral) RN - 0 (Antioxidants) RN - 0 (Havcr1 protein, mouse) RN - 0 (Hepatitis A Virus Cellular Receptor 1) RN - 0 (Membrane Proteins) RN - 0 (Organophosphorus Compounds) RN - 0 (cystinosin protein, mouse) RN - 11062-77-4 (Superoxides) RN - 1339-63-5 (Ubiquinone) RN - 47BYS17IY0 (mitoquinone) SB - IM MH - Adaptation, Physiological/*physiology MH - Amino Acid Transport Systems, Neutral/deficiency/genetics/metabolism MH - Animals MH - Antioxidants/pharmacology MH - Apoptosis/drug effects MH - Cystinosis/genetics/*pathology/*physiopathology MH - Disease Models, Animal MH - Female MH - Hepatitis A Virus Cellular Receptor 1 MH - Kidney Tubules, Proximal/metabolism/*pathology/*physiopathology MH - Male MH - Membrane Proteins/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Mitochondria/drug effects MH - Mutation/genetics MH - Organophosphorus Compounds/pharmacology MH - Oxidative Stress/*physiology MH - Superoxides/metabolism MH - Ubiquinone/analogs & derivatives/pharmacology OTO - NOTNLM OT - cystinosis OT - mitoquinone OT - oxidative injury OT - proximal tubule OT - swan-neck lesion EDAT- 2015/02/20 06:00 MHDA- 2015/08/05 06:00 CRDT- 2015/02/20 06:00 PHST- 2014/10/24 00:00 [received] PHST- 2015/02/09 00:00 [accepted] PHST- 2015/02/20 06:00 [entrez] PHST- 2015/02/20 06:00 [pubmed] PHST- 2015/08/05 06:00 [medline] AID - ajprenal.00591.2014 [pii] AID - 10.1152/ajprenal.00591.2014 [doi] PST - ppublish SO - Am J Physiol Renal Physiol. 2015 May 15;308(10):F1155-66. doi: 10.1152/ajprenal.00591.2014. Epub 2015 Feb 18.